Pharma industry and DoP to enhance stakeholder intervention for SPI Scheme
Pharma industry and DoP to enhance stakeholder intervention for SPI Scheme
Stay updated with breaking news from Common Facilities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharma industry and DoP to enhance stakeholder intervention for SPI Scheme
In a fresh blow to the Indian pharmaceutical industry, the World Health Organisation (WHO) has warned against the use of two Indian cough syrups for children that have been linked to at least 18 deaths in Uzbekistan in December last year. The WHO said the products manufactured by Marion Biotech, a N
University College backtracks over decision to restrict heating for students after significant backlash and clash at town hall meeting.
With a total financial outlay of Rs 500 crore for the period from FY 21-22 to FY 25-26, the pharmaceutical department under the Ministry of Chemicals and Fertilisers released the guidelines for the Strengthening of Pharmaceutical Industry (SPI) ...
The objectives of the scheme are to strengthen the existing infrastructure facilities in order to make India a global leader in the pharma sector, the government said.